Add BrightSurf on Google Email

Insurance delays and denials mean kids don’t get allergy and asthma medications

A new study found that 4 in 10 requests for children's biologic medications were denied, with delays taking weeks and putting kids at risk. The study suggests changes to the prior authorization process to make it faster and simpler, allowing children to access necessary medications without long waits.

SourceAmerican College of Allergy, Asthma, and Immunology·JournalAnnals of Allergy Asthma & Immunology·TypeData/statistical analysis·DateNov 12, 2026

New strategy identified for treating lupus

Researchers have identified a new strategy for treating lupus by targeting an imbalance in prolactin receptors, reducing inflammatory molecules and kidney damage while preserving healthy immune cells. This approach could potentially control disease activity and reduce the risk of organ damage.

SourceUniversity of California - Riverside·JournalExperimental & Molecular Medicine·TypeExperimental study·DateNov 2, 2026

Treg-stromal cell axis in tissue repair and autoimmune diseases: Mechanisms and clinical translation

The Treg-stromal cell axis plays a central role in coordinating immune tolerance, inflammation resolution, and tissue regeneration. Disruption of this axis contributes to autoimmune diseases, and targeting it may restore healthy repair, rather than just suppressing immunity.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalRheumatology & Autoimmunity·TypeSystematic review·DateOct 29, 2026

How dismissed symptoms can push patients to breaking point

A new study reveals concerns about misdiagnosis and stigma in autoimmune diseases with functional neurological disorder (FND), highlighting the need for better communication and holistic care. Patients and clinicians often see things differently, and poor explanations can lead to feelings of guilt, shame, and suicidal thoughts.

SourceUniversity of East Anglia·JournalRheumatology International·TypeSurvey·DateOct 26, 2026

A shared driver, three different barriers: Review maps mitochondrial oxidative stress as a therapeutic target in rheumatoid arthritis, lupus and multiple sclerosis

Mitochondrial oxidative stress is a key driver of autoimmune diseases, with each disease having unique barriers to treatment. The review proposes a single therapeutic target, targeting the interconnected regulatory network of five pathways, including NRF2, AMPK, SIRT1, and mitophagy.

SourceMedicine Discovery·JournalMedicine Discovery·TypeLiterature review·DateOct 21, 2026

UCLA gene therapy pioneer Dr. Donald Kohn elected to National Academy of Medicine

Dr. Donald Kohn, a renowned pediatric bone marrow transplant physician and gene therapy researcher, has been elected to the National Academy of Medicine for his groundbreaking work in blood stem cell gene therapies. His lab has made significant contributions to treating ADA-SCID, severe leukocyte adhesion deficiency-I, and other diseas...

Continuous glucose monitors help type 2 diabetes patients spend five more hours a day in healthy blood sugar range

A large-scale clinical trial found that adults using continuous glucose monitors (CGMs) spent approximately 5 additional hours each day within their target blood sugar range compared to those receiving routine care. Nearly twice as many CGM users achieved an A1c level below 7%, a common treatment goal for people with diabetes.

SourceUniversity of Colorado Anschutz·JournalNew England Journal of Medicine·DateOct 14, 2026

New global survey shines a light on the patients who rely on plasma-derived medicines—and the donors who make them possible

A global survey of over 1,100 patients, caregivers, and healthcare providers found that 69% noticed a change in their health or someone they care for within a few months of plasma-derived medicine treatment, with 77% expressing gratitude to donors. The survey also revealed high confidence in plasma-derived medicines' safety and efficacy.

Wiskott-Aldrich Syndrome: Long-term results of gene therapy developed at the San Raffaele-Telethon Institute published in the New England Journal of Medicine

A novel autologous gene therapy for Wiskott-Aldrich syndrome has demonstrated durable clinical benefits in a phase 3 study, with 96% survival at 1 and 5 years. The treatment, etu-cel, has also reduced severe infections and moderate-to-severe bleeding events.

SourceFondazione Telethon·TypeRandomized controlled/clinical trial·DateSep 24, 2026

International study sets new standards for arthritis ultrasound diagnosis

An international study has established age-specific ultrasound reference values to distinguish normal joint changes from early signs of inflammatory arthritis. The study analysed over 28,000 joints from 802 healthy volunteers and developed new thresholds for normal and abnormal findings, which will help clinicians identify inflammatory...

SourceUniversity of Birmingham·JournalThe Lancet Rheumatology·TypeObservational study·DateSep 23, 2026

Scientists uncover shared biology behind profound fatigue in five major illnesses

A new study reveals striking biological similarities between five major illnesses, including long Covid and PTSD, suggesting common underlying mechanisms. Chronic fatigue syndrome, rheumatoid arthritis, and multiple sclerosis may be driven by shared regulatory networks in immune and metabolic systems.

SourceUniversity of East Anglia·JournalJournal of Translational Medicine·TypeComputational simulation/modeling·DateSep 2, 2026

Pet dog microbiota may protect young children from respiratory tract infections and reduce the need for antibiotic courses

A recent Finnish study found that exposure to dog-associated microbes in early childhood reduces the risk of respiratory tract infections and antibiotic courses. Dog ownership is linked to higher richness and diversity of microbiota, but not directly associated with reduced infection rates.

SourceFinnish Institute for Health and Welfare·JournalPediatric Allergy and Immunology·DateAug 3, 2026

Unearthing new cancer treatments from fungi

Researchers have developed a gene-editing tool that unlocks the secrets of fungi, a kingdom rich in antibacterial compounds. The tool, called fPE7max, enables precise control over DNA sequences and has identified three novel molecules with anti-cancer properties.

SourceUniversity of Pennsylvania·JournalNature Biotechnology·TypeExperimental study·DateJul 2, 2026

Gut fungi may hold the key to treating Asthma worldwide

Two studies found that certain fungal species in the gut play a key role in immune dysregulation and pediatric allergic diseases, positioning the infant mycobiome as a promising target for therapies. Infants' early-life antibiotic use may have a direct impact on these fungi, leading to immune dysregulation and allergic asthma.

SourceUniversity of Calgary·JournalNature Communications·TypeData/statistical analysis·DateJun 23, 2026

New review highlights how modern rheumatoid arthritis treatments can protect bone health

A new review highlights advances in preventing bone loss in people with rheumatoid arthritis, showing that modern antirheumatic therapies can significantly reduce both localized erosions and generalized bone loss. Emerging imaging technologies like HR-pQCT have been found to detect subtle bone erosions earlier and more sensitively.

SourceInternational Osteoporosis Foundation·JournalCalcified Tissue International·TypeLiterature review·DateJun 10, 2026